Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
2024's Driving Clearing Robots: Master Suggestions and Surveys - 2'Seditious behavior': Trump accuses Democrats who made video reminding the military not to follow illegal orders of a crime — but is it?
- 3Most loved Amusement Park Firecrackers Show: Which One Lights Up Your Evening?
- 46 US States for Fly Fishing
- 5Living in the dark: Gaza’s struggle for electricity
- Happy with Running Shoes for 2024
- KJ Apa stars as Jimmy Stewart in new biopic: See his transformation
- Figure out How to Put resources into Lab Precious stones
- Dental Embed Innovation: An Achievement in Helpful Dentistry
- Activists Took BMW and Mercedes to Court Over Gas Cars. It Didn’t Stick
- A definitive Manual for 2024's Most In vogue Wedding Dresses
- 'Everyone in this prison has had family killed or shot'
- Data centers in space: Will 2027 really be the year AI goes to orbit?
- Ariana Grande to host 'Saturday Night Live' Christmas show with Cher as musical guest, returning after nearly 40 years
